{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/5a468153-0110-4568-be63-f63969349653/6502341fcda2400011704d44?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Disruption and innovation in the biopharmaceutical industry: An interview with GSK’s chief commercial officer Luke Miels","description":"<p>In this episode of <em>The Heidrick &amp; Struggles Leadership Podcast</em>, Heidrick &amp; Struggles’ Charlie Moore speaks to Luke Miels, the chief commercial officer at GSK, a global biopharmaceutical company headquartered in London. In this interview, Miels discusses the changing healthcare industry, both from an R&amp;D perspective and from a commercial perspective, highlighting the changing digital and AI environment and sharing how the profile of the successful leader is changing as a result. He also discusses some tips for collaboration between R&amp;D and commercial teams, the challenges of change management, and GSK’s culture journey. Finally, he offers advice for leaders and aspiring leaders looking to build a career within a pharmaceutical company.</p>","author_name":"Heidrick & Struggles"}